Renaissance Technologies - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 278 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$49,982
-12.8%
3,230,900
-11.5%
0.08%
+2.4%
Q2 2023$57,341
+17.0%
3,650,000
+22.8%
0.08%
+27.7%
Q1 2023$49,002
+9.7%
2,973,400
+3.8%
0.06%
+6.6%
Q4 2022$44,685
-99.9%
2,864,400
+0.5%
0.06%
+17.3%
Q3 2022$36,953,000
-6.9%
2,849,100
+0.7%
0.05%
+10.6%
Q2 2022$39,709,000
+39.1%
2,828,300
+41.9%
0.05%
+42.4%
Q1 2022$28,543,000
+21.8%
1,993,200
+16.0%
0.03%
+13.8%
Q4 2021$23,427,000
-33.7%
1,718,800
-20.3%
0.03%
-37.0%
Q3 2021$35,330,000
-8.6%
2,156,900
-6.1%
0.05%
-4.2%
Q2 2021$38,659,000
-38.4%
2,297,000
-33.1%
0.05%
-38.5%
Q1 2021$62,716,000
-38.2%
3,434,600
-38.4%
0.08%
-29.1%
Q4 2020$101,532,000
-0.8%
5,578,700
-2.8%
0.11%
+7.8%
Q3 2020$102,343,000
+1.8%
5,736,707
+2.3%
0.10%
+17.2%
Q2 2020$100,546,000
+76.0%
5,607,700
+49.0%
0.09%
+58.2%
Q1 2020$57,128,000
+44.2%
3,763,400
+87.4%
0.06%
+83.3%
Q4 2019$39,622,000
+35.2%
2,008,189
+17.8%
0.03%
+20.0%
Q3 2019$29,316,000
+114.0%
1,704,400
+120.3%
0.02%
+108.3%
Q2 2019$13,696,000773,8000.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Adelphi Capital LLP 7,931,116$140,381,00032.92%
Endurant Capital Management LP 932,967$16,514,0006.51%
Glenview Capital Management 26,430,828$467,826,0004.24%
Paulson & Co. 13,244,711$234,431,0003.98%
Blackcrane Capital, LLC 172,955$3,061,0003.88%
NINE MASTS CAPITAL Ltd 1,474,286$26,146,0003.74%
Velanne Asset Management Ltd 286,640$5,074,0003.22%
LMR Partners LLP 4,563,591$80,884,0002.95%
SECTOR GAMMA AS 796,299$14,094,0002.26%
MFN Partners Management, LP 785,000$13,895,0002.21%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders